This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignees: Salk Institute for Biological Studies, Sanford Burnham Prebys Medical Discovery Institute. Active years: 2026.
Company Filing History:
1 out of 4 
1 out of 99 
Years Active: 2026
Title: Sonja N Brun: Innovator in Cancer Research
Introduction
Sonja N Brun is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of cancer research through her innovative work on ULK1/2 inhibitors. Her research focuses on developing compounds that can potentially treat and prevent diseases mediated by ULK, including various forms of cancer.
Latest Patents
Sonja N Brun holds 1 patent for her invention titled "Macrocyclic ULK1/2 inhibitors." This patent encompasses compounds, compositions, formulations, and methods aimed at addressing ULK-mediated diseases. The implications of her work are profound, as they may lead to new therapeutic strategies for cancer treatment.
Career Highlights
Throughout her career, Sonja has been associated with esteemed institutions such as the Salk Institute for Biological Studies and the Sanford Burnham Prebys Medical Discovery Institute. Her work at these organizations has allowed her to collaborate with leading scientists and contribute to groundbreaking research in the field of biology and medicine.
Collaborations
Sonja has worked alongside talented colleagues, including Allison S Limpert and Nicole A Bakas. These collaborations have enriched her research and fostered an environment of innovation and discovery.
Conclusion
Sonja N Brun's contributions to cancer research through her innovative patents and collaborations highlight her role as a leading inventor in the scientific community. Her work continues to inspire advancements in the treatment of ULK-mediated diseases.